Login / Signup

Corticosteroids in septic shock: a systematic review and network meta-analysis.

Ben GibbisonJosé A López-LópezJulian P T HigginsTom MillerGianni D AngeliniStafford L LightmanDjillali Annane
Published in: Critical care (London, England) (2017)
There was no clear evidence that any one corticosteroid drug or treatment regimen is more likely to be effective in reducing mortality or reducing the incidence of gastrointestinal bleeding or superinfection in septic shock. Hydrocortisone delivered as a bolus or as an infusion was more likely than placebo and methylprednisolone to result in shock reversal.
Keyphrases
  • septic shock
  • risk factors
  • low dose
  • high dose
  • randomized controlled trial
  • combination therapy
  • coronary artery disease